Back to Search Start Over

Four Cases of Suspected Levetiracetam-Induced Asymptomatic Rhabdomyolysis.

Authors :
Saito S
Iijima M
Ikeguchi R
Ishizuka K
Kitagawa K
Source :
Cureus [Cureus] 2023 Jul 10; Vol. 15 (7), pp. e41666. Date of Electronic Publication: 2023 Jul 10 (Print Publication: 2023).
Publication Year :
2023

Abstract

Rhabdomyolysis is a known side effect of levetiracetam. In general, a patient with rhabdomyolysis complains of muscle pain and swelling. Herein, we report four cases of asymptomatic levetiracetam-induced rhabdomyolysis. In all the four cases, the seizures resolved after more than five days. The patients received continuous fluid replacement from the time they were admitted to our hospital. However, serum creatine kinase (CK) levels continued to rise without symptoms consistent with rhabdomyolysis. The serum CK level improved rapidly when levetiracetam was replaced with lacosamide. Because levetiracetam occasionally causes asymptomatic rhabdomyolysis, routine blood tests should be performed after its initiation.<br />Competing Interests: The authors have declared that no competing interests exist.<br /> (Copyright © 2023, Saito et al.)

Details

Language :
English
ISSN :
2168-8184
Volume :
15
Issue :
7
Database :
MEDLINE
Journal :
Cureus
Publication Type :
Report
Accession number :
37575737
Full Text :
https://doi.org/10.7759/cureus.41666